网站综合信息 www.mozobil.com
- 标题:
- Mozobil (plerixafor injection)
- 关键字:
- 描述:
- Official site from Genzyme Corporation. Contains consumer and prescribing information.
- 域名信息
- 域名年龄:19年7个月19天 注册日期:2004年09月07日 到期时间:2018年09月07日
邮箱:domainabuse 电话:+1.8887802723
注册商:CSC CORPORATE DOMAINS, INC.
- 服务器空间
- IP:205.137.77.100 同IP网站1个 详情
地址:美国
- 备案信息
- 备案号:
域名流量Alexa排名
域名注册Whois信息
mozobil.com
域名年龄: 19年7个月19天注册时间: 2004-09-07
到期时间: 2018-09-07
注 册 商: CSC CORPORATE DOMAINS, INC.
注册邮箱: domainabuse
联系电话: +1.8887802723
获取时间: 2016年10月10日 23:55:34
Domain Name: MOZOBIL.COM
Registrar: CSC CORPORATE DOMAINS, INC.
Sponsoring Registrar IANA ID: 299
Whois Server: whois.corporatedomains.com
Referral URL: http://www.cscglobal.com/global/web/csc/digital-brand-services.html
Name Server: NS1.SANOFI-SYNTHELABO.COM
Name Server: NS2.SANOFI-SYNTHELABO.COM
Name Server: NS3.SANOFI-SYNTHELABO.COM
Name Server: NS4.SANOFI-SYNTHELABO.COM
Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Updated Date: 2016-09-03
Creation Date: 2004-09-07
Expiration Date: 2018-09-07
>>> Last update of whois database: Mon, 2016-Oct-10 15:59:08 GMT <<<
For more information on Whois status codes, please visit https://icann.org/epp
Domain Name: mozobil.com
Domain ID: 129423281_DOMAIN_COM-VRSN
WHOIS Server: whois.corporatedomains.com
Referral URL: www.cscprotectsbrands.com
Updated Date: 2016-09-03T05:25:08Z
Creation Date: 2004-09-07T21:57:53Z
Registry Expiry Date: 2018-09-07T21:57:53Z
Sponsoring Registrar: CSC CORPORATE DOMAINS, INC.
Sponsoring Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse
Registrar Abuse Contact Phone: +1.8887802723
Domain Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
Registry Registrant ID:
Registrant Name: Genzyme Corporation
Registrant Organization: Genzyme Corporation
Registrant Street: 15 Pleasant Street Connector
Registrant City: Framingham
Registrant State/Province: MA
Registrant Postal Code: 01701
Registrant Country: US
Registrant Phone: +1.5082702184
Registrant Phone Ext:
Registrant Fax: +1.5088721035
Registrant Fax Ext:
Registrant Email: dns_admin
Registry Admin ID:
Admin Name: DNS Master
Admin Organization: Sanofi
Admin Street: Sanofi
Admin City: Antony
Admin State/Province: .
Admin Postal Code: 92160
Admin Country: FR
Admin Phone: +33.141245875
Admin Phone Ext:
Admin Fax: +33.141241502
Admin Fax Ext:
Admin Email: domain.names
Registry Tech ID:
Tech Name: DNS Master
Tech Organization: Sanofi
Tech Street: Sanofi
Tech City: MASSY
Tech State/Province: .
Tech Postal Code: 91349
Tech Country: FR
Tech Phone: +33.141245838
Tech Phone Ext:
Tech Fax: +33.141247016
Tech Fax Ext:
Tech Email: gtly-domtech
Name Server: ns3.sanofi-synthelabo.com
Name Server: ns2.sanofi-synthelabo.com
Name Server: ns4.sanofi-synthelabo.com
Name Server: ns1.sanofi-synthelabo.com
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2016-09-03T05:25:08Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
Corporation Service Company(c) (CSC) The Trusted Partner of More than 50% of the 100 Best Global Brands.
Contact us to learn more about our enterprise solutions for Global Domain Name Registration and Management, Trademark Research and Watching, Brand, Logo and Auction Monitoring, as well SSL Certificate Services and DNS Hosting.
NOTICE: You are not authorized to access or query our WHOIS database through the use of high-volume, automated, electronic processes or for the purpose or purposes of using the data in any manner that violates these terms of use. The Data in the CSC WHOIS database is provided by CSC for information purposes only, and to assist persons in obtaining information about or related to a domain name registration record. CSC does not guarantee its accuracy. By submitting a WHOIS query, you agree to abide by the following
Register your domain name at http://www.cscglobal.
网站头文件(HTTP Header)
HTTP/1.1 200 OK 缓存控制:private 类型:text/html; charset=utf-8 服务器:Microsoft-IIS/8.5 X-AspNetMvc-Version: 3.0 ASP.NET版本:4.0.30319 设置Cookie:ai_session=23d5f3df81894d0c91b52f96c08d16ae|2016-10-10T15:59:08.1202328+00:00|2016-10-10T15:59:08.1515275+00:00; expires=Mon, 10-Oct-2016 16:29:08 GMT; path=/ 设置Cookie:ai_user=427f707044074b929273822fdd1fbbfa|2016-10-10T15:59:08.1202328+00:00; expires=Fri, 31-Dec-9999 23:59:59 GMT; path=/ LB_SERVER: 2 访问时间:2016年10月10日 23:59:07 文件大小:18705 设置Cookie:NLB_DMZ=1459474077.57375.0000; path=/ 网站编码:utf-8
同IP网站(同服务器)
其他后缀域名
网站首页快照(纯文字版)
抓取时间:2016年10月10日 23:55:28
网址:http://www.mozobil.com/
标题:Mozobil (plerixafor injection)
关键字:
描述:Official site from Genzyme Corporation. Contains consumer and prescribing information.
主体:
网址:http://www.mozobil.com/
标题:Mozobil (plerixafor injection)
关键字:
描述:Official site from Genzyme Corporation. Contains consumer and prescribing information.
主体:
For U.S. Residents OnlyPrescribing InformationPrescribing InformationImportant Safety InformationPATIENTS & FAMILIESHEALTHCARE PROFESSIONALSFor U.S. Residents OnlySearch:1-877-4MOZOBIL(1-877-466-9624)Important Safety Information| Full Prescribing Information Important Safety Information for Mozobil (plerixafor injection) Severe, life-threatening allergic reactions (anaphylaxis) can happen in people who take Mozobil. Tell your doctor right away if you experience hives (itchy raised bumps), eye swelling, or trouble breathing. View additional Important Safety Information. Raise your expectations for apheresis success in non-Hodgkin's lymphoma (NHL) and multiple myleoma (MM) patients with Mozobil + granulocyte-colony stimulating factor (G-CSF) compared to G-CSF alone. Patients & FamiliesClick here Healthcare ProfessionalsClick here Mozobil (pronounced MOH-zuh-bil), a hematopoietic stem cell mobilizer, is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with NHL and MM. Indication Mozobil (plerixafor injection) is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM). Important Safety Information for Mozobil (plerixafor injection) Severe, life-threatening allergic reactions (anaphylaxis) can happen in people who take Mozobil. Tell your doctor right away if you experience hives (itchy raised bumps), eye swelling, or trouble breathing. Mozobil is not intended for hematopoietic stem cell transplantation (HSCT) mobilization and collection in patients with leukemia. Mozobil in combination with G-CSF increases circulating white blood cells (WBCs). Your WBC counts will be monitored. Thrombocytopenia (a decrease in the number of platelets circulating in the blood) has been observed in patients receiving Mozobil. Your platelet counts will be monitored. Cancer cells may be released from the bone marrow and subsequently collected along with your stem cells during apheresis. The potential effects of infusing cancer cells during your transplant have not been well-studied. Your spleen may be examined if you experience pain in the left upper stomach area or left shoulder area as these may be signs of an enlarged or burst (ruptured) spleen. Mozobil may harm the unborn child when administered to a pregnant woman. Scientific studies have shown that Mozobil causes harm to unborn animals. The safety of Mozobil in pregnant women has not been established in clinical trials. If you are of childbearing potential you should be advised to avoid becoming pregnant while receiving treatment with Mozobil. If this drug is used during pregnancy, or if you become pregnant while taking this drug, you should be app
最近查询网站